Table of Contents
Pharmaceutics, Volume 9, Issue 2 (June 2017)
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story This artwork depicts the use of poly(styrene-co-maleic-anhydride) (SMA) conjugated folic acid (FA) [...] Read more. This artwork depicts the use of poly(styrene-co-maleic-anhydride) (SMA) conjugated folic acid (FA) to enhance the aqueous solubility of a highly hydrophobic anticancer compound 3,4- difluorobenzylidene diferuloylmethane (CDF) and accumulation of targeted formulation at the tumor sites via folate receptor-mediated endocytosis due to the specific binding of folic acid to folate receptors overexpressed on retinoblastoma cells (Y-79). Thus, the formulation will enhance the permeability and retention effect of the CDF drug and will also increase its cytotoxic effect on cancer cells. View the paper.